Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZINCGNAO1
2024-512735-72-00Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of zinc acetate in GNAO1-associated disorder (GNAO1), sponsored by University of Cologne. Primary endpoints: Feasibility of oral zinc treatment and Safety of oral zinc treatment. Started Jun 2024; status: completed.
02
Drugs
zinc acetate
03
Conditions
GNAO1-associated disorder (GNAO1)
Beyond the preview
Go deeper on 2024-512735-72-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512735-72-00.